ENTERIS BIOPHARMA

Enteris BioPharma is the partner of choice for developing oral BCS-III and BCS-IV drug products, including oral peptides, peptidomimetics, and small molecules. The Peptelligence® and ProPerma® oral drug delivery technologies have been proven safe and effective in numerous clinical trials, enabling significant treatment opportunities for which there is no oral delivery option. With a purpose-built, state-of-the-art facility, Enteris offers end-to-end oral drug product development from formulation and proof-of-concept to clinical and commercial manufacturing for the most challenging APIs... Enteris also offers IND Phase 1 & 2 clinical manufacturing services for orally inhaled and nasal (powder and liquid) drug products.

Also known as: Enteris, Enteris BioPharma, Inc.

Primary location: Boonton United States